| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| D A White, A H Robin. An analysis of 17 catatonic patients diagnosed with neuroleptic malignant syndrome. CNS spectrums. vol 5. issue 7. 2012-10-02. PMID:18197157. |
in all patients diagnosed with nms in the authors' series, catatonia was an invariable prodromal state. |
2012-10-02 |
2023-08-12 |
Not clear |
| D A White, A H Robin. An analysis of 17 catatonic patients diagnosed with neuroleptic malignant syndrome. CNS spectrums. vol 5. issue 7. 2012-10-02. PMID:18197157. |
the authors, therefore, challenge the separate nosological status of nms and catatonia and suggest that these syndromes are part of a unitary pathophysiological disorder. |
2012-10-02 |
2023-08-12 |
Not clear |
| Ho-Dong Choi, Kyoung-Keun Kim, Bon-Hoon Ko. A case of catatonia and neuroleptic malignant syndrome probably associated with antipsychotic in Korea. Psychiatry investigation. vol 8. issue 2. 2011-11-10. PMID:21852996. |
several studies have reported on catatonia caused by the use of antipsychotic drugs and on the association between catatonia and neuroleptic malignant syndrome (nms), but none has reported such a case in korea. |
2011-11-10 |
2023-08-12 |
Not clear |
| Ho-Dong Choi, Kyoung-Keun Kim, Bon-Hoon Ko. A case of catatonia and neuroleptic malignant syndrome probably associated with antipsychotic in Korea. Psychiatry investigation. vol 8. issue 2. 2011-11-10. PMID:21852996. |
here, we report the case of a 20-year-old woman whose catatonia and nms appeared associated with the administration of an atypical antipsychotic drug. |
2011-11-10 |
2023-08-12 |
Not clear |
| Ho-Dong Choi, Kyoung-Keun Kim, Bon-Hoon Ko. A case of catatonia and neuroleptic malignant syndrome probably associated with antipsychotic in Korea. Psychiatry investigation. vol 8. issue 2. 2011-11-10. PMID:21852996. |
we discuss the association between nms and catatonia due to neuroleptic use. |
2011-11-10 |
2023-08-12 |
Not clear |
| Takayasu Mishima, Yoshio Tsuboi, Masa-Aki Higuchi, Jun Tsugawa, Toyoshi Obata, Tatsuo Yamad. [Diazepam-responsive malignant catatonia in a patient with an initial clinical diagnosis of neuroleptic malignant syndrome: a case report]. Brain and nerve = Shinkei kenkyu no shinpo. vol 63. issue 5. 2011-07-05. PMID:21515931. |
we report a case of malignant catatonia initially diagnosed as neuroleptic malignant syndrome (nms) that responded successfully to diazepam administration. |
2011-07-05 |
2023-08-12 |
Not clear |
| Takayasu Mishima, Yoshio Tsuboi, Masa-Aki Higuchi, Jun Tsugawa, Toyoshi Obata, Tatsuo Yamad. [Diazepam-responsive malignant catatonia in a patient with an initial clinical diagnosis of neuroleptic malignant syndrome: a case report]. Brain and nerve = Shinkei kenkyu no shinpo. vol 63. issue 5. 2011-07-05. PMID:21515931. |
the diagnosis of malignant catatonia was confirmed because treatment with diazepam was dramatically effective, whereas the initial treatment for nms was not beneficial. |
2011-07-05 |
2023-08-12 |
Not clear |
| Takayasu Mishima, Yoshio Tsuboi, Masa-Aki Higuchi, Jun Tsugawa, Toyoshi Obata, Tatsuo Yamad. [Diazepam-responsive malignant catatonia in a patient with an initial clinical diagnosis of neuroleptic malignant syndrome: a case report]. Brain and nerve = Shinkei kenkyu no shinpo. vol 63. issue 5. 2011-07-05. PMID:21515931. |
the clinical presentation of malignant catatonia is similar to that of nms. |
2011-07-05 |
2023-08-12 |
Not clear |
| Takayasu Mishima, Yoshio Tsuboi, Masa-Aki Higuchi, Jun Tsugawa, Toyoshi Obata, Tatsuo Yamad. [Diazepam-responsive malignant catatonia in a patient with an initial clinical diagnosis of neuroleptic malignant syndrome: a case report]. Brain and nerve = Shinkei kenkyu no shinpo. vol 63. issue 5. 2011-07-05. PMID:21515931. |
indeed, some authors have described nms as a variant of malignant catatonia. |
2011-07-05 |
2023-08-12 |
Not clear |
| Takayasu Mishima, Yoshio Tsuboi, Masa-Aki Higuchi, Jun Tsugawa, Toyoshi Obata, Tatsuo Yamad. [Diazepam-responsive malignant catatonia in a patient with an initial clinical diagnosis of neuroleptic malignant syndrome: a case report]. Brain and nerve = Shinkei kenkyu no shinpo. vol 63. issue 5. 2011-07-05. PMID:21515931. |
if treatment is refractory in cases of nms, malignant catatonia may be suspected, and changing treatment to diazepam administration may be useful. |
2011-07-05 |
2023-08-12 |
Not clear |
| Michele Fornar. Catatonia: a narrative review. Central nervous system agents in medicinal chemistry. vol 11. issue 1. 2011-06-17. PMID:21294706. |
what is clear is that neurotransmitters, such as dopamine (da), gamma-aminobutyric acid (gaba), and glutamate (glu), are of major importance in the pathogenesis of catatonia and neuroleptic malignant syndrome (nms) and that serotonin (5-hydroxytryptamine [5-ht]) is crucial to the development of serotonin syndrome (ss). |
2011-06-17 |
2023-08-12 |
Not clear |
| Francesco Casamassima, Lorenzo Lattanzi, Roy H Perlis, Antonella Litta, Erika Fui, Ubaldo Bonuccelli, Gregory Fricchione, Giovanni B Cassan. Neuroleptic malignant syndrome: further lessons from a case report. Psychosomatics. vol 51. issue 4. 2010-10-25. PMID:20587766. |
neuroleptic malignant syndrome (nms) represents an iatrogenic form of malignant catatonia, and simple catatonia has been shown to predispose to nms. |
2010-10-25 |
2023-08-12 |
Not clear |
| Thomas Paparrigopoulos, Elias Tzavellas, Panagiotis Ferentinos, Iraklis Mourikis, John Liappa. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. vol 10. issue 1. 2009-08-19. PMID:19673089. |
catatonia is characterized by the predominance of psychomotor abnormalities and shares many clinical, biological and treatment response features with the neuroleptic malignant syndrome (nms), a rare adverse reaction to psychoactive medications. |
2009-08-19 |
2023-08-12 |
Not clear |
| Thomas Paparrigopoulos, Elias Tzavellas, Panagiotis Ferentinos, Iraklis Mourikis, John Liappa. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. vol 10. issue 1. 2009-08-19. PMID:19673089. |
a case of a 49-year-old woman, who developed nms while on low dose clozapine soon after recovering from catatonia, is presented. |
2009-08-19 |
2023-08-12 |
Not clear |
| Thomas Paparrigopoulos, Elias Tzavellas, Panagiotis Ferentinos, Iraklis Mourikis, John Liappa. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. vol 10. issue 1. 2009-08-19. PMID:19673089. |
the potential relationship between catatonia and nms is discussed in the light of the existing literature, and attention is drawn to the risk for clozapine-induced nms in catatonic patients. |
2009-08-19 |
2023-08-12 |
Not clear |
| M Chandran, M El-Shazl. Catatonia, neuroleptics and brain damage--a case report. Journal of psychopharmacology (Oxford, England). vol 23. issue 2. 2009-07-28. PMID:18562406. |
the authors present a case of amisulpiride-induced catatonia, further evaluation suggested neuroleptic malignant syndrome (nms) and showed the occurrence of temporal lobe epilepsy (tle) and underlying brain pathology with marked frontoparietal atrophy and periventricular white matter hyperintensities. |
2009-07-28 |
2023-08-12 |
Not clear |
| Brendan T Carroll, Joseph W Y Lee, Kevin T Graham, Arthur Thalassinos, Christopher Thomas, Rob Kirkhar. Diagnosing subtypes of neuroleptic malignant syndrome: an introduction to the Lee-Carroll Scale. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 20. issue 1. 2008-04-07. PMID:18297586. |
neuroleptic malignant syndrome (nms) shares common features with catatonia and serotonin syndrome (ss). |
2008-04-07 |
2023-08-12 |
Not clear |
| Brendan T Carroll, Joseph W Y Lee, Kevin T Graham, Arthur Thalassinos, Christopher Thomas, Rob Kirkhar. Diagnosing subtypes of neuroleptic malignant syndrome: an introduction to the Lee-Carroll Scale. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 20. issue 1. 2008-04-07. PMID:18297586. |
for instance, catatonia is a risk factor for the development of nms. |
2008-04-07 |
2023-08-12 |
Not clear |
| Duangjai Kasantikul, Buranee Kanchanatawa. Neuroleptic malignant syndrome: a review and report of six cases. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. vol 89. issue 12. 2007-12-17. PMID:17214072. |
the typical symptoms and signs of neuroleptic malignant syndrome (nms) consist of fever muscle rigidity (stiffness, myoclonus, rod-like), alterations of consciousness (confusion, agitation, aggression, or catatonia), autonomic nervous system disturbances (i.e., hypertension, tachycardia, tachypnea, profuse sweating, and urine incontinence), abnormal blood tests such as low serum electrolytes, elevated serum creatinine phosphokinase (cpk) level, and leukocytosis. |
2007-12-17 |
2023-08-12 |
Not clear |
| E Vancaester, P Santen. Catatonia and neuroleptic malignant syndrome: two sides of a coin? Acta neurologica Belgica. vol 107. issue 2. 2007-09-28. PMID:17710840. |
since catatonia shares a number of symptoms with the neuroleptic malignant syndrome (nms) and similar treatments can be used in both conditions, it has also been suggested that nms and catatonia are two variants of the same disorder in this article we describe five cases of catatonia and nms in order to approach this nosological question. |
2007-09-28 |
2023-08-12 |
Not clear |